Status:
COMPLETED
Autonomic Recalibration
Lead Sponsor:
Edward Via Virginia College of Osteopathic Medicine
Conditions:
Chronic Pain (Back / Neck)
Autonomic Dysregulation
Eligibility:
All Genders
21-80 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if Autonomic Recalibration works to reduce sympathetic dominance to alleviate dysfunctional myofascial pain. The main questions it aims to answer are: How ...
Detailed Description
Myofascial pain contributes to opioid misuse and opioid use disorder. Alternative non-drug therapies for myofascial pain, such as osteopathic manipulative treatment, are critical areas of research. An...
Eligibility Criteria
Inclusion
- dysfunctional myofascial pain, i.e., ongoing pain not relevant to an acute perturbation (e.g., recent injury) or known underlying condition (e.g., cancer).
Exclusion
- known skin allergies to gel as found in common cosmetic or household products
- can't make treatment appointments on two consecutive days
- myofascial pain is deemed functional (normal response to acute injury or ongoing pathology)
- lacking a COVID-19 vaccination and a booster shot.
Key Trial Info
Start Date :
April 27 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 27 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06603168
Start Date
April 27 2023
End Date
February 27 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Edward Via College of Osteopathic Medicine, Auburn Campus
Auburn, Alabama, United States, 36832